Report cover image

Global Granisetron Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 203 Pages
SKU # APRC20562009

Description

Summary

According to APO Research, The global Granisetron market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Granisetron include Kyowa Kirin, Teva, Sandoz, Mylan, Fresenius Kabi, Wockhardt, Taro Pharmaceutical, Natco Pharma and Hikma Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Granisetron, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Granisetron, also provides the revenue of main regions and countries. Of the upcoming market potential for Granisetron, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Granisetron revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Granisetron market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Granisetron revenue, projected growth trends, production technology, application and end-user industry.

Granisetron Segment by Company

Kyowa Kirin
Teva
Sandoz
Mylan
Fresenius Kabi
Wockhardt
Taro Pharmaceutical
Natco Pharma
Hikma Pharmaceuticals
Heron Therapeutics
Dr.Reddy's
Cipla
Bluepharma
Aurobindo
APOTEX
Akorn
Granisetron Segment by Type

Injection
Transdermal system
Oral
Granisetron Segment by Application

Chemotherapy
Post operative
Granisetron Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granisetron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Granisetron and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granisetron.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Granisetron in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Granisetron company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Granisetron revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

203 Pages
1 Market Overview
1.1 Product Definition
1.2 Granisetron Market by Type
1.2.1 Global Granisetron Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Transdermal system
1.2.4 Oral
1.3 Granisetron Market by Application
1.3.1 Global Granisetron Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Chemotherapy
1.3.3 Post operative
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Granisetron Market Dynamics
2.1 Granisetron Industry Trends
2.2 Granisetron Industry Drivers
2.3 Granisetron Industry Opportunities and Challenges
2.4 Granisetron Industry Restraints
3 Global Growth Perspective
3.1 Global Granisetron Market Perspective (2020-2031)
3.2 Global Granisetron Growth Trends by Region
3.2.1 Global Granisetron Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Granisetron Market Size by Region (2020-2025)
3.2.3 Global Granisetron Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Granisetron Revenue by Players
4.1.1 Global Granisetron Revenue by Players (2020-2025)
4.1.2 Global Granisetron Revenue Market Share by Players (2020-2025)
4.1.3 Global Granisetron Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Granisetron Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Granisetron Key Players Headquarters & Area Served
4.4 Global Granisetron Players, Product Type & Application
4.5 Global Granisetron Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Granisetron Market CR5 and HHI
4.6.3 2024 Granisetron Tier 1, Tier 2, and Tier 3
5 Granisetron Market Size by Type
5.1 Global Granisetron Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Granisetron Revenue by Type (2020-2031)
5.3 Global Granisetron Revenue Market Share by Type (2020-2031)
6 Granisetron Market Size by Application
6.1 Global Granisetron Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Granisetron Revenue by Application (2020-2031)
6.3 Global Granisetron Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Kyowa Kirin
7.1.1 Kyowa Kirin Comapny Information
7.1.2 Kyowa Kirin Business Overview
7.1.3 Kyowa Kirin Granisetron Revenue and Gross Margin (2020-2025)
7.1.4 Kyowa Kirin Granisetron Product Portfolio
7.1.5 Kyowa Kirin Recent Developments
7.2 Teva
7.2.1 Teva Comapny Information
7.2.2 Teva Business Overview
7.2.3 Teva Granisetron Revenue and Gross Margin (2020-2025)
7.2.4 Teva Granisetron Product Portfolio
7.2.5 Teva Recent Developments
7.3 Sandoz
7.3.1 Sandoz Comapny Information
7.3.2 Sandoz Business Overview
7.3.3 Sandoz Granisetron Revenue and Gross Margin (2020-2025)
7.3.4 Sandoz Granisetron Product Portfolio
7.3.5 Sandoz Recent Developments
7.4 Mylan
7.4.1 Mylan Comapny Information
7.4.2 Mylan Business Overview
7.4.3 Mylan Granisetron Revenue and Gross Margin (2020-2025)
7.4.4 Mylan Granisetron Product Portfolio
7.4.5 Mylan Recent Developments
7.5 Fresenius Kabi
7.5.1 Fresenius Kabi Comapny Information
7.5.2 Fresenius Kabi Business Overview
7.5.3 Fresenius Kabi Granisetron Revenue and Gross Margin (2020-2025)
7.5.4 Fresenius Kabi Granisetron Product Portfolio
7.5.5 Fresenius Kabi Recent Developments
7.6 Wockhardt
7.6.1 Wockhardt Comapny Information
7.6.2 Wockhardt Business Overview
7.6.3 Wockhardt Granisetron Revenue and Gross Margin (2020-2025)
7.6.4 Wockhardt Granisetron Product Portfolio
7.6.5 Wockhardt Recent Developments
7.7 Taro Pharmaceutical
7.7.1 Taro Pharmaceutical Comapny Information
7.7.2 Taro Pharmaceutical Business Overview
7.7.3 Taro Pharmaceutical Granisetron Revenue and Gross Margin (2020-2025)
7.7.4 Taro Pharmaceutical Granisetron Product Portfolio
7.7.5 Taro Pharmaceutical Recent Developments
7.8 Natco Pharma
7.8.1 Natco Pharma Comapny Information
7.8.2 Natco Pharma Business Overview
7.8.3 Natco Pharma Granisetron Revenue and Gross Margin (2020-2025)
7.8.4 Natco Pharma Granisetron Product Portfolio
7.8.5 Natco Pharma Recent Developments
7.9 Hikma Pharmaceuticals
7.9.1 Hikma Pharmaceuticals Comapny Information
7.9.2 Hikma Pharmaceuticals Business Overview
7.9.3 Hikma Pharmaceuticals Granisetron Revenue and Gross Margin (2020-2025)
7.9.4 Hikma Pharmaceuticals Granisetron Product Portfolio
7.9.5 Hikma Pharmaceuticals Recent Developments
7.10 Heron Therapeutics
7.10.1 Heron Therapeutics Comapny Information
7.10.2 Heron Therapeutics Business Overview
7.10.3 Heron Therapeutics Granisetron Revenue and Gross Margin (2020-2025)
7.10.4 Heron Therapeutics Granisetron Product Portfolio
7.10.5 Heron Therapeutics Recent Developments
7.11 Dr.Reddy's
7.11.1 Dr.Reddy's Comapny Information
7.11.2 Dr.Reddy's Business Overview
7.11.3 Dr.Reddy's Granisetron Revenue and Gross Margin (2020-2025)
7.11.4 Dr.Reddy's Granisetron Product Portfolio
7.11.5 Dr.Reddy's Recent Developments
7.12 Cipla
7.12.1 Cipla Comapny Information
7.12.2 Cipla Business Overview
7.12.3 Cipla Granisetron Revenue and Gross Margin (2020-2025)
7.12.4 Cipla Granisetron Product Portfolio
7.12.5 Cipla Recent Developments
7.13 Bluepharma
7.13.1 Bluepharma Comapny Information
7.13.2 Bluepharma Business Overview
7.13.3 Bluepharma Granisetron Revenue and Gross Margin (2020-2025)
7.13.4 Bluepharma Granisetron Product Portfolio
7.13.5 Bluepharma Recent Developments
7.14 Aurobindo
7.14.1 Aurobindo Comapny Information
7.14.2 Aurobindo Business Overview
7.14.3 Aurobindo Granisetron Revenue and Gross Margin (2020-2025)
7.14.4 Aurobindo Granisetron Product Portfolio
7.14.5 Aurobindo Recent Developments
7.15 APOTEX
7.15.1 APOTEX Comapny Information
7.15.2 APOTEX Business Overview
7.15.3 APOTEX Granisetron Revenue and Gross Margin (2020-2025)
7.15.4 APOTEX Granisetron Product Portfolio
7.15.5 APOTEX Recent Developments
7.16 Akorn
7.16.1 Akorn Comapny Information
7.16.2 Akorn Business Overview
7.16.3 Akorn Granisetron Revenue and Gross Margin (2020-2025)
7.16.4 Akorn Granisetron Product Portfolio
7.16.5 Akorn Recent Developments
8 North America
8.1 North America Granisetron Revenue (2020-2031)
8.2 North America Granisetron Revenue by Type (2020-2031)
8.2.1 North America Granisetron Revenue by Type (2020-2025)
8.2.2 North America Granisetron Revenue by Type (2026-2031)
8.3 North America Granisetron Revenue Share by Type (2020-2031)
8.4 North America Granisetron Revenue by Application (2020-2031)
8.4.1 North America Granisetron Revenue by Application (2020-2025)
8.4.2 North America Granisetron Revenue by Application (2026-2031)
8.5 North America Granisetron Revenue Share by Application (2020-2031)
8.6 North America Granisetron Revenue by Country
8.6.1 North America Granisetron Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Granisetron Revenue by Country (2020-2025)
8.6.3 North America Granisetron Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Granisetron Revenue (2020-2031)
9.2 Europe Granisetron Revenue by Type (2020-2031)
9.2.1 Europe Granisetron Revenue by Type (2020-2025)
9.2.2 Europe Granisetron Revenue by Type (2026-2031)
9.3 Europe Granisetron Revenue Share by Type (2020-2031)
9.4 Europe Granisetron Revenue by Application (2020-2031)
9.4.1 Europe Granisetron Revenue by Application (2020-2025)
9.4.2 Europe Granisetron Revenue by Application (2026-2031)
9.5 Europe Granisetron Revenue Share by Application (2020-2031)
9.6 Europe Granisetron Revenue by Country
9.6.1 Europe Granisetron Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Granisetron Revenue by Country (2020-2025)
9.6.3 Europe Granisetron Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Granisetron Revenue (2020-2031)
10.2 China Granisetron Revenue by Type (2020-2031)
10.2.1 China Granisetron Revenue by Type (2020-2025)
10.2.2 China Granisetron Revenue by Type (2026-2031)
10.3 China Granisetron Revenue Share by Type (2020-2031)
10.4 China Granisetron Revenue by Application (2020-2031)
10.4.1 China Granisetron Revenue by Application (2020-2025)
10.4.2 China Granisetron Revenue by Application (2026-2031)
10.5 China Granisetron Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Granisetron Revenue (2020-2031)
11.2 Asia Granisetron Revenue by Type (2020-2031)
11.2.1 Asia Granisetron Revenue by Type (2020-2025)
11.2.2 Asia Granisetron Revenue by Type (2026-2031)
11.3 Asia Granisetron Revenue Share by Type (2020-2031)
11.4 Asia Granisetron Revenue by Application (2020-2031)
11.4.1 Asia Granisetron Revenue by Application (2020-2025)
11.4.2 Asia Granisetron Revenue by Application (2026-2031)
11.5 Asia Granisetron Revenue Share by Application (2020-2031)
11.6 Asia Granisetron Revenue by Country
11.6.1 Asia Granisetron Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Granisetron Revenue by Country (2020-2025)
11.6.3 Asia Granisetron Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Granisetron Revenue (2020-2031)
12.2 SAMEA Granisetron Revenue by Type (2020-2031)
12.2.1 SAMEA Granisetron Revenue by Type (2020-2025)
12.2.2 SAMEA Granisetron Revenue by Type (2026-2031)
12.3 SAMEA Granisetron Revenue Share by Type (2020-2031)
12.4 SAMEA Granisetron Revenue by Application (2020-2031)
12.4.1 SAMEA Granisetron Revenue by Application (2020-2025)
12.4.2 SAMEA Granisetron Revenue by Application (2026-2031)
12.5 SAMEA Granisetron Revenue Share by Application (2020-2031)
12.6 SAMEA Granisetron Revenue by Country
12.6.1 SAMEA Granisetron Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Granisetron Revenue by Country (2020-2025)
12.6.3 SAMEA Granisetron Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.